Heroin

"Heroin" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

A narcotic analgesic that may be habit-forming. It is a controlled substance (opium derivative) listed in the U.S. Code of Federal Regulations, Title 21 Parts 329.1, 1308.11 (1987). Sale is forbidden in the United States by Federal statute. (Merck Index, 11th ed)

Descriptor ID	D003932
MeSH Number(s)	D03.132.577.249.562.445 D03.605.497.607.490 D03.633.400.686.607.490 D04.615.723.795.576.445
Concept/Terms	Heroin Heroin Diacetylmorphine Diamorphine Diagesil Diagesil Diamorf Min-I-Jet Morphine Sulphate Min-I-Jet Morphine Sulphate Min I Jet Morphine Sulphate Heroin Hydrochloride Heroin Hydrochloride Hydrochloride, Heroin Diacetylmorphine Hydrochloride Hydrochloride, Diacetylmorphine

Below are MeSH descriptors whose meaning is more general than "Heroin".

Chemicals and Drugs [D]
Heterocyclic Compounds [D03]
Alkaloids [D03.132]
Opiate Alkaloids [D03.132.577]
Morphinans [D03.132.577.249]
Morphine Derivatives [D03.132.577.249.562]
Heroin [D03.132.577.249.562.445]
Heterocyclic Compounds, Bridged-Ring [D03.605]
Morphinans [D03.605.497]
Morphine Derivatives [D03.605.497.607]
Heroin [D03.605.497.607.490]
Heterocyclic Compounds, Fused-Ring [D03.633]
Heterocyclic Compounds, 4 or More Rings [D03.633.400]
Morphinans [D03.633.400.686]
Morphine Derivatives [D03.633.400.686.607]
Heroin [D03.633.400.686.607.490]
Polycyclic Compounds [D04]
Polycyclic Aromatic Hydrocarbons [D04.615]
Phenanthrenes [D04.615.723]
Morphinans [D04.615.723.795]
Morphine Derivatives [D04.615.723.795.576]
Heroin [D04.615.723.795.576.445]

Below are MeSH descriptors whose meaning is related to "Heroin".

Below are MeSH descriptors whose meaning is more specific than "Heroin".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Heroin" by people in this website by year, and whether "Heroin" was a major or minor topic of these publications.

Bar chart showing 15 publications over 11 distinct years, with a maximum of 2 publications in 2006 and 2012 and 2018 and 2024

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
2002	1	0	1
2004	1	0	1
2006	0	2	2
2010	0	1	1
2011	1	0	1
2012	1	1	2
2016	0	1	1
2018	2	0	2
2020	0	1	1
2021	0	1	1
2024	0	2	2

Below are the most recent publications written about "Heroin" by people in Profiles.

Gilbert LR, Tawiah NA, Adepoju OE. Exploring racial and secondary substance use differences in route of administration of opioid drugs: Analysis of the 2015-2019 treatment admission data. J Subst Use Addict Treat. 2024 07; 162:209365.

View in: PubMed
Luo SX, Feaster DJ, Liu Y, Balise RR, Hu MC, Bouzoubaa L, Odom GJ, Brandt L, Pan Y, Hser YI, VanVeldhuisen P, Castillo F, Calderon AR, Rotrosen J, Saxon AJ, Weiss RD, Wall M, Nunes EV. Individual-Level Risk Prediction of Return to Use During Opioid Use Disorder Treatment. JAMA Psychiatry. 2024 01 01; 81(1):45-56.

View in: PubMed
Baum MK, Tamargo JA, Ehman RL, Sherman KE, Chen J, Liu Q, Mandler RN, Teeman C, Martinez SS, Campa A. Heroin use is associated with liver fibrosis in the Miami Adult Studies on HIV (MASH) cohort. Drug Alcohol Depend. 2021 03 01; 220:108531.

View in: PubMed
Tamargo JA, Campa A, Martinez SS, Li T, Sherman KE, Zarini G, Meade CS, Mandler RN, Baum MK. Cognitive Impairment among People Who Use Heroin and Fentanyl: Findings from the Miami Adult Studies on HIV (MASH) Cohort. J Psychoactive Drugs. 2021 Jul-Aug; 53(3):215-223.

View in: PubMed
Syvertsen JL, Agot K, Ohaga S, Bazzi AR. You can't do this job when you are sober: Heroin use among female sex workers and the need for comprehensive drug treatment programming in Kenya. Drug Alcohol Depend. 2019 01 01; 194:495-499.

View in: PubMed
Tong J, Fitzmaurice PS, Moszczynska A, Rathitharan G, Ang LC, Meyer JH, Mizrahi R, Boileau I, Furukawa Y, McCluskey T, Sailasuta N, Kish SJ. Normal glutathione levels in autopsied brain of chronic users of heroin and of cocaine. Drug Alcohol Depend. 2018 09 01; 190:20-28.

View in: PubMed
Syvertsen JL, Ohaga S, Agot K, Dimova M, Guise A, Rhodes T, Wagner KD. An ethnographic exploration of drug markets in Kisumu, Kenya. Int J Drug Policy. 2016 Apr; 30:82-90.

View in: PubMed
Price EP, Seymour ML, Sarovich DS, Latham J, Wolken SR, Mason J, Vincent G, Drees KP, Beckstrom-Sternberg SM, Phillippy AM, Koren S, Okinaka RT, Chung WK, Schupp JM, Wagner DM, Vipond R, Foster JT, Bergman NH, Burans J, Pearson T, Brooks T, Keim P. Molecular epidemiologic investigation of an anthrax outbreak among heroin users, Europe. Emerg Infect Dis. 2012 Aug; 18(8):1307-13.

View in: PubMed
Ruiz-Col?n K, Mart?nez MA, Silva-Torres LA, Chavez-Arias C, Mel?ndez-Negr?n M, Conte-Miller MS, Bloom-Oquendo J. Simultaneous determination of xylazine, free morphine, codeine, 6-acetylmorphine, cocaine and benzoylecgonine in postmortem blood by UPLC-MS-MS. J Anal Toxicol. 2012 Jun; 36(5):319-26.

View in: PubMed
Clatts MC, Goldsamt LA, Giang le M, Col?n-L?pez V. Accelerated transition to injection among male heroin initiates in Hanoi, Vietnam: implications for early harm reduction interventions. J Community Health. 2011 Dec; 36(6):999-1003.

View in: PubMed

People

Explore

Similar Concepts

Top Journals